Amicus Therapeutics, Inc. (FOLD)
14.46
+0.01
(+0.07%)
USD |
NASDAQ |
Apr 17, 16:00
14.46
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics SG&A Expense (Quarterly) : 117.08M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 446.21M |
| Insmed, Inc. | 212.48M |
| Ligand Pharmaceuticals, Inc. | 25.03M |
| Penumbra, Inc. | 181.10M |
| MannKind Corp. | 58.41M |